Bal Pharma Limited (NSE:BALPHARMA)

Bal Pharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	80.51	41.96	14.87	11.13	10.23
Short-Term Investments	24.68	157.33	59.76	47.3	29.48
Cash & Short-Term Investments	105.19	199.29	74.63	58.43	39.71
Cash Growth	-47.22%	167.05%	27.72%	47.14%	13.24%
Accounts Receivable	924.44	996.22	939.76	753.12	671.97
Other Receivables	-	32.81	27.56	51.87	42.99
Receivables	935.76	1,043	976.92	828.67	735.6
Inventory	1,030	878.11	980.05	743.96	603.85
Prepaid Expenses	-	9.69	7.2	5.86	0.8
Other Current Assets	277.55	211.67	242.77	208.79	261.51
Total Current Assets	2,349	2,341	2,282	1,846	1,641
Property, Plant & Equipment	737.76	620.77	621.79	571.85	575.09
Long-Term Investments	-	2.81	13.98	18.09	23.86
Goodwill	38.27	38.29	38.29	38.29	38.29
Other Intangible Assets	119.98	12.47	13.16	2.09	0.59
Long-Term Deferred Tax Assets	4.1	24.12	21.67	-	-
Long-Term Deferred Charges	-	101.34	91.41	77.83	71.89
Other Long-Term Assets	108.08	52.82	48.9	47.53	45.78
Total Assets	3,357	3,195	3,132	2,605	2,401
Accounts Payable	816.86	774.64	789.23	655.64	471.67
Accrued Expenses	11.67	37.77	34.69	70.82	58.64
Short-Term Debt	-	957.61	927.17	707.49	821.21
Current Portion of Long-Term Debt	1,190	74.88	77.6	58.79	52.72
Current Portion of Leases	-	12.77	8.55	7.62	3.08
Current Income Taxes Payable	-	22.18	60.06	43.93	6.14
Other Current Liabilities	176.48	150.57	196.06	112.17	111.88
Total Current Liabilities	2,195	2,030	2,093	1,656	1,525
Long-Term Debt	314.13	363.49	305.23	270.14	239.32
Long-Term Leases	17.28	13.74	12.25	22.54	16.15
Long-Term Deferred Tax Liabilities	-	39.61	28.69	6.04	26.32
Other Long-Term Liabilities	56.45	12.75	12.8	25.42	24.72
Total Liabilities	2,583	2,503	2,495	2,020	1,867
Common Stock	159.21	158.04	156.9	148.22	148.22
Additional Paid-In Capital	-	312.87	301.84	266.77	266.77
Retained Earnings	-	217.93	171.4	160.33	119.03
Comprehensive Income & Other	614.95	4.09	7.75	10.95	1.79
Total Common Equity	774.16	692.94	637.89	586.27	535.82
Minority Interest	-0.12	-0.33	-0.87	-1.34	-2.28
Shareholders' Equity	774.04	692.61	637.02	584.92	533.54
Total Liabilities & Equity	3,357	3,195	3,132	2,605	2,401
Total Debt	1,521	1,423	1,331	1,067	1,132
Net Cash (Debt)	-1,416	-1,223	-1,256	-1,008	-1,093
Net Cash Per Share	-89.50	-77.39	-80.06	-68.02	-76.96
Filing Date Shares Outstanding	19.81	15.8	15.69	15.57	14.82
Total Common Shares Outstanding	19.81	15.8	15.69	14.82	14.82
Working Capital	153.72	311.04	188.22	189.26	116.15
Book Value Per Share	39.09	43.85	40.66	39.55	36.15
Tangible Book Value	615.92	642.19	586.45	545.89	496.94
Tangible Book Value Per Share	31.10	40.63	37.38	36.83	33.53
Land	-	148.93	148.93	79.1	79.1
Buildings	-	233.21	222.2	214.15	208.79
Machinery	-	643.87	613.08	558.05	539.09
Construction In Progress	-	4.72	-	16.12	-

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.